Trial · NCT07913828
Two Doses of IV Magnesium Sulfate for Prevention of Post-Spinal Shivering
NCT07913828, Phase 4, Not yet recruiting, Suez Canal University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Two Doses of IV Magnesium Sulfate for Prevention of Post-Spinal Shivering. Trials, record NCT07913828. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07913828
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Two Doses of IV Magnesium Sulfate for Prevention of Post-Spinal Shivering
- NCT number
- NCT07913828
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 82 participants, estimated
- Lead sponsor
- Suez Canal University
- Conditions
- Post Spinal Anesthesia Shivering
- Interventions
- Magnesium Sulfate 50 mg/kg IV, Magnesium Sulfate 30 mg/kg IV
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Clinically Significant Post-Spinal Shivering (Crossley-Mahajan Grade ≥3) | From immediately after spinal anesthesia until 60 minutes after spinal anesthesia | |
| Secondary | Severity of Post-Spinal Shivering (Crossley-Mahajan Grade 0-4) | From immediately after spinal anesthesia until 60 minutes after spinal anesthesia | |
| Secondary | Time to Onset of Post-Spinal Shivering | From immediately after spinal anesthesia until the first occurrence of shivering, assessed for up to 60 minutes after spinal anesthesia. | |
| Secondary | Cumulative Dose of Intravenous Pethidine Used as Rescue Treatment for Post-Spinal Shivering | From the onset of clinically significant shivering until discharge from the recovery room. | Cumulative dose of intravenous pethidine administered as rescue treatment for clinically significant shivering (Crossley-Mahajan Grade ≥3). |
| Secondary | Systolic, Diastolic, and Mean Arterial Blood Pressure | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Heart rate | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Core Body Temperature | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Sedation Score Assessed Using the Modified Ramsay Sedation Scale | Immediately before spinal anesthesia (baseline), and at 0, 5, 10, 15, 20, 25, 30, 45, and 60 minutes after spinal anesthesia. | |
| Secondary | Apgar Score at 1 and 5 Minutes After Birth | At 1 and 5 minutes after birth. | |
| Secondary | Need for Neonatal Respiratory Support | From birth through 24 hours after birth. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07913828
GET https://conductscience.org/api/trials/v1/NCT07913828/registered